HIGHLIGHTS
- who: Yu-Peng Han and collaborators from the University of California, San Francisco, United States have published the research work: Autophagy and its therapeutic potential in diabetic nephropathy, in the Journal: (JOURNAL)
- what: The symptomatic treatment for DN usually includes glycemic control, reducing albuminuria, and blocking RAS with the usage of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin
- future: The role of autophagy in the progression of DN sheds light on treating DN and how to keep the balance of autophagy in the diabetic kidney may be a new direction for prevention and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.